Manuel Serrano wins the 48th Leopold Griffuel Award for fundamental cancer research


Manuel Serrano, Head of the Cell Plasticity and Senescence lab at IRB Barcelona, has been recognised for his important contributions to the field of cell biology.

Each endowed with €150,000, the Leopold Griffuel Awards are given yearly to two researchers whose exceptional work has accelerated the fight against cancer.

 

On 2 December, Manuel Serrano, ICREA researcher at IRB Barcelona whose laboratory is supported by the "la Caixa" Foundation, received the 48th  Leopold Griffuel Award for fundamental cancer research, granted by the Fondation ARC.

The French foundation has presented him this prize for his important contributions to the field of cell biology and, in particular, to understanding oncogenesis and cellular plasticity.

"I am very honoured and grateful for this recognition. The Fondation ARC carries out very important work because it highlights the relevance of fundamental research, as well as clinical research, in the fight against cancer," says Serrano.

 

Cell plasticity, senescent cells and oncogenesis

Serrano's work is internationally acknowledged and has been the seed of many research projects. Serrano identified and characterised the p16 gene, one of the most important genes in cancer protection. His current studies focus on senescence and cell plasticity and their role in embryonic development, tissue regeneration and anti-oncogenic response.

 

The award in the category of clinical and translational research

In this 48th edition, the Leopold Griffuel Prize in the category of clinical and translational research has been given to Michel Sadelain, at the Memorial Sloan Kettering Cancer Center. Saledain is an immunologist specialising in anti-tumour cell therapy whose work has greatly contributed to the development of CAR-T cells.

 

More information: Fondation ARC